The Future of Pulmonary Hypertension

Oct 1, 2016 by in RESPIRATORY Comments Off on The Future of Pulmonary Hypertension

Knowledge gap Strategy Example of present or future state Unifying theory of PH across WHO groups Cross-sectional deep phenotyping; consensus phenotypic definitions NHLBI PVD phenomics; consensus documents [1] Predicting PAH…

read more

Determining the Optimal Approach to Initiating Oral, Inhaled, and Intravenous Therapies in Clinical Practice: Sequential Goal-Directed Therapy Is Best

Oct 1, 2016 by in RESPIRATORY Comments Off on Determining the Optimal Approach to Initiating Oral, Inhaled, and Intravenous Therapies in Clinical Practice: Sequential Goal-Directed Therapy Is Best

Fig. 17.1 Two approaches to initiation of therapy in PAH: sequential combination therapy or up-front combination therapy A. Sequential Combination Therapy. Treatment is initiated with monotherapy and the outcome assessed….

read more

Renin-Angiotensin-Aldosterone and Other Neurohumoral Factors in the Pathogenesis of Pulmonary Hypertension

Oct 1, 2016 by in RESPIRATORY Comments Off on Renin-Angiotensin-Aldosterone and Other Neurohumoral Factors in the Pathogenesis of Pulmonary Hypertension

Vessel type Artery Mean α1-AR density (fmol/mg protein) Arteries Central Aorta 9.8 ± 1.8 Small somatic Mammary 6.0 ± 1.3 Splanchnic Mesenteric 13 ± 6.1  Splenic 28 ± 7.7  Hepatic 28 ± 5.9 Renal Renal 23 ± 5.9 Pulmonary Pulmonary artery 24 ± 5.2…

read more

The Effects of Chronic Hypoxia on Inflammation and Pulmonary Vascular Function

Oct 1, 2016 by in RESPIRATORY Comments Off on The Effects of Chronic Hypoxia on Inflammation and Pulmonary Vascular Function

Fig. 5.1 Proposed intra- and inter-cellular signaling mechanisms involved in fibroblast-macrophage crosstalk in chronic non-resolving perivascular inflammation underlying irreversible pulmonary vascular remodeling. In this process, the adventitial fibroblast undergoes epigenetic…

read more

Genetics of Pulmonary Vascular Disease

Oct 1, 2016 by in RESPIRATORY Comments Off on Genetics of Pulmonary Vascular Disease

Fig. 6.1 Molecular pathogenesis of hereditary PAH. BMP binds to BMPR2. Upon ligand binding, the type II receptor phosphorylates a type I receptor, including ALK1, ALK2, ALK3 or ALK6. This…

read more

Contemporary Pharmacotherapies Involving Nitric Oxide, Prostacyclin, and Endothelin Receptor Signaling Pathways

Oct 1, 2016 by in RESPIRATORY Comments Off on Contemporary Pharmacotherapies Involving Nitric Oxide, Prostacyclin, and Endothelin Receptor Signaling Pathways

Fig. 16.1 Pulmonary artery smooth muscle cell therapeutic targets and corresponding licensed (green boxes) and investigational (red boxes) treatment approaches for pulmonary arterial hypertension. Arrows represent receptor stimulation, whereas terminated…

read more

The Defining Characteristics of Pulmonary Arterial Hypertension

Oct 1, 2016 by in RESPIRATORY Comments Off on The Defining Characteristics of Pulmonary Arterial Hypertension

Hypoxic signaling HIF-1α/HIF-2α TGF-β ERK1/2 Increased Ca++ Mitochondrial dysfunction Mitochondrial hyperpolarization Suppressed mitophagy Increased mROS generation HIF-1α and aerobic glycolysis Quasi malignancy Clonal endothelial cell proliferation Microsatellite instability Somatic chromosomal…

read more

Support Care for the Pulmonary Hypertension Patient

Oct 1, 2016 by in RESPIRATORY Comments Off on Support Care for the Pulmonary Hypertension Patient

Fig. 21.1 The pulmonary hypertension clinical patient care continuum. The Pulmonary Hypertension Clinical (PHC) care coordinator plays a pivotal role in coordinating each element of the treatment plan individualized to…

read more

Determining the Optimal Approach to Initiating Oral, Inhaled, and Intravenous Therapies in Clinical Practice: Maximal Upfront Therapy Is Best

Oct 1, 2016 by in RESPIRATORY Comments Off on Determining the Optimal Approach to Initiating Oral, Inhaled, and Intravenous Therapies in Clinical Practice: Maximal Upfront Therapy Is Best

Fig. 18.1 Example of a potential induction therapy protocol. If a similar protocol were to be transformed into a clinical trial, an additional arm could include dual oral therapy. A…

read more
Get Clinical Tree app for offline access